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Abstract
Background—Access to healthcare, particularly effective primary and secondary preventive
care, is critical for cancer survivors, in order to minimize the adverse sequelae of cancer and its
treatment.
Purpose—The goal of the study was to evaluate the association between cancer survivorship and
access to primary and preventive health care.
Methods—Cancer survivors (n=4960) and individuals without a cancer history (n=64,431) aged
≥18 years, from the 2008–2010 Medical Expenditure Panel Survey (MEPS), were evaluated.
Multiple measures of access and preventive services use were compared. The association between
cancer survivorship and access and preventive services was evaluated with multivariate logistic
regression models, stratified by age group (18–64 years and ≥65 years), controlling for the effects
of age, gender, race/ethnicity, education, marital status, and comorbidities. Data were analyzed in
2013.
Results—Cancer survivors aged ≥65 years had equivalent or greater access and preventive
services use than individuals without a cancer history, in adjusted analyses. However, among
those aged 18–64 years with private health insurance, cancer survivors were more likely than other
individuals to have a usual source of care and to use preventive services, whereas uninsured or
publicly insured cancer survivors were generally less likely to have a usual source of care and to
use preventive services than were uninsured or publicly insured adults without a cancer history.
Conclusions—Although access and preventive care use in cancer survivors is generally
equivalent or greater compared to that of other individuals, disparities for uninsured and publicly
insured cancer survivors aged 18–64 years suggest that improvements in survivor care are needed.
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Introduction
In 2008, there were approximately 12 million individuals with a history of cancer in the
U.S.1 The prevalence of cancer survivorship is expected to increase dramatically in the
future, due to the aging and growth of the U.S. population,1,2 and longer survival after
diagnosis. However, cancer survivors have an increased risk of secondary cancers,3 may
experience lasting or late effects of treatment,4 and are more likely to report worse health
than individuals without a cancer history.5,6
Therefore, access to health care, particularly effective primary and secondary preventive
care, is critical for cancer survivors, in order to minimize the adverse sequelae of cancer and
its treatment. The 2005 IOM report, From Cancer Patient to Cancer Survivor: Lost in
Transition, emphasized the importance of ensuring high-quality and ongoing preventive care
for survivors.7 The Affordable Care Act will expand health insurance coverage to the
previously uninsured and encourage use of preventive care.8
Having health insurance and a usual source of healthcare is consistently associated with
greater preventive services use9 and diagnosis and treatment of chronic conditions.10 Even
though newly diagnosed uninsured cancer patients may be medically eligible for Medicaid
coverage during initial treatment in some states,11 longer-term cancer survivors may face
barriers to maintaining insurance coverage and to care access.12 They may also forgo care
because of cost.12,13
Findings from studies that compared preventive services use for cancer survivors and
individuals without a cancer history are mixed.14–20 Some report less preventive services
use by cancer survivors,15-17 whereas others report greater use.14,16,18 Most studies
reporting less preventive services use were conducted in cohorts of elderly Medicare
beneficiaries at similar times since diagnosis, using the linked SEER-Medicare data.15,17,21
Studies reporting similar or greater preventive services use were conducted in samples of
prevalent survivors of all ages and cancer types, with all types of health insurance (including
the uninsured), and a range of times since diagnosis.14,18–20 However, no prior population-
based study has evaluated access to care or explored the role of insurance coverage in detail.
Considering these discrepant findings, more detailed comparisons of preventive service use
in cancer survivors and individuals without a cancer history by age, insurance, and times
since diagnosis are warranted. Age-related variation in preventive services use can reflect
differential insurance coverage and access between older and younger populations. More
than 95% of the population aged ≥65 years is enrolled in the Medicare program, whereas
insurance for the younger population is more heterogeneous, and a substantial proportion is
uninsured.22 Additionally, the elderly use more health care than younger populations.23
Differences in preventive service use between cancer survivors and other individuals also
vary by age due to greater healthcare contact in elderly than younger populations without a
cancer history.
In the current study, national data were used to evaluate access to care and preventive
services use by adult cancer survivors compared to adults without a cancer history,
separately for the elderly and non-elderly and within health insurance type. Access and
preventive services use were also evaluated by time since diagnosis for cancer survivors.
Findings will provide an important baseline for understanding access to care in cancer
survivors prior to the scheduled implementation of the Affordable Care Act.
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Methods
Sample
The sample was based on pooled data from 3 years (2008–2010) of the Medical Expenditure
Panel Survey (MEPS) Household Component, which is nationally representative of the U.S.
civilian non-institutionalized population. The MEPS is an ongoing survey of healthcare
expenditures, insurance, utilization, and access to care. Data collection is initiated with a
new sample (i.e., “panel”) each year that is followed for 2 years in five rounds of in-person
interviews with a family member who typically responds for all family members in the
household. Overlapping panels are combined for each MEPS annual file, and the combined
average annual response rate for 2008–2010 was approximately 60%. More information
about survey design and content is available from www.meps.ahrq.gov/mepsweb/.
Adult cancer survivors (n = 4960) were identified from a question about whether a doctor or
other health professional had ever told them that they had cancer or a malignancy of any
kind. Respondents were asked about the cancer type and age at diagnosis, for each
diagnosis. The remaining 64,431 adults with no cancer history were the comparison group
(125 individuals with missing data for this question were excluded). Individuals diagnosed
with solely nonmelanoma skin cancer were not classified as cancer survivors.
Measures
Covariates: Sample characteristics used in the analysis were age, gender, race/ethnicity,
marital status, education, and insurance type. Conditions other than cancer were ascertained
with a series of questions about whether a doctor or other health professional ever told the
person they had any MEPS priority conditions, including arthritis, asthma, hypertension,
angina, coronary heart disease, stroke, diabetes, high cholesterol, heart attack, and
emphysema. Conditions were categorized by the absolute number of priority conditions for
each individual. Time since cancer diagnosis was calculated as the difference between age at
first diagnosis and age at the interview (i.e., <2 years, 2–5 years, 6–10 years, and ≥11 years)
for cancer survivors.5,6
Outcomes: Access to care was conceptualized as either perceived or realized based on an
adaptation of Anderson and Aday's behavioral model of access to health care24 to reflect
distinctions between perceptions about availability of care and actual utilization of
healthcare services. Perceived access to care was measured in questions about a usual source
of health care and ability to access, or delays in necessary medical care, dental care, or
prescription medication. Realized access to care was measured by questions about
preventive services use and cancer screening recommended by the U.S. Preventive Services
Task Force25 and available in the MEPS, consistent with other studies.15-18 Preventive
services included blood pressure and cholesterol evaluations within 2 years, and a dental
check-up and an influenza vaccination within the past year.
Cancer screening was assessed among age- and gender-eligible women and men.
Mammography within 2 years in women aged ≥40 years, Pap testing within 3 years in
women aged ≥ 21 years who had not had their cervix removed, and home fecal occult blood
testing within 1 year or endoscopy within 5 years among women and men aged ≥50 years
were used to measure breast, cervical, and colorectal cancer screening, respectively. To
ensure that these tests were for screening rather than surveillance for recurrence, test use was
evaluated among only individuals without a specific cancer diagnosis, as has been done
previously.18
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Data Analysis
Descriptive statistics were calculated for cancer survivors and other individuals stratified by
age group (18–64 years, ≥65 years), and distributions were compared with chi-square
statistics. All estimates were weighted to account for the MEPS complex survey design and
survey nonresponse using SUDAAN. The association between cancer survivorship and
access to care was evaluated, stratified by age group and controlling for age, gender, race/
ethnicity, educational attainment, marital status, and number of comorbid conditions, using
multivariate logistic regression. Analyses were further stratified by insurance type and time
since cancer diagnosis.
Wald statistics were used to test the significance of differences between cancer survivors
and other individuals, the interaction between cancer survivorship and insurance type, and
time since diagnosis among cancer survivors. Analyses did not consider multiple
comparisons, but instead the discussion of results focuses on consistent patterns of findings
across measures. Unadjusted bivariate estimates and adjusted predicted marginals are
presented from the multivariate regression analyses. The predictive margins method26
directly standardizes the outcome of each group to the covariate distribution of the overall
population. Standardized results can be compared like percentages. All tests of significance
were two-sided. Because diagnosis dates for comorbid conditions in relation to cancer
treatment(s) were not available, conditions could have preceded the cancer diagnosis and its
treatment(s) or developed afterwards, potentially as a late or lasting effect of treatment. To
understand the potential impact of either assumption about comorbidity, sensitivity analyses
were conducted without controlling for comorbidities. The results of the two sets of analyses
were similar, and adjusted estimates that control for comorbidities are presented.
Results
Cancer survivors were more likely to be older and have more comorbid conditions than
individuals without a cancer history; these differences were more pronounced in the group
aged 18–64 years than the group aged ≥65 years (Table 1). In both age groups, cancer
survivors were more likely to have higher educational attainment and be non-Hispanic white
than other individuals. In the younger group, cancer survivors were more likely to have
either private or public insurance and less likely to be uninsured than individuals without a
cancer history. In the older group, cancer survivors were more likely to have Medicare and
private supplemental health insurance. The most common cancer diagnoses were breast and
prostate (data not shown). In both age groups, most cancer survivors were diagnosed 6 or
more years prior to the survey, with fewer cancer survivors diagnosed within 2 years or 2–5
years prior to the survey.
Perceived Access to Care
Cancer survivors aged 18–64 years were more likely to have a usual source of care than
their counterparts without a cancer history, in adjusted analyses (Table 2). Having a usual
source of care was not different for older groups. Associations between cancer survivorship
and usual source of care varied by type of health insurance for the younger population, in
adjusted analyses. Regardless of cancer history, the percentage with a usual source of care
was highest among individuals with private insurance, lower for publicly insured, and
lowest for the uninsured. Among the privately insured, cancer survivors were more likely
than individuals without a cancer history to have a usual source of care, but among the
publicly insured or uninsured, cancer survivors were less likely to have a usual source of
care (Figure 1; p-value= 0.02 for interaction between insurance type and cancer history).
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Among the younger group, cancer survivors were more likely to be unable to get or to delay
in getting necessary medical care compared to individuals without a cancer history (16.0%
vs 12.8%, p<0.001). Being unable to get or delayed in getting necessary care was similar for
cancer survivors and individuals without a cancer history with private health insurance
(11.2% vs 9.5%), but worse for cancer survivors with public insurance (26.1% vs 19.5%) or
who were uninsured (29.0% vs 22.1%), although the interaction for health insurance type
and cancer history was not significant (p=0.341).
Regardless of cancer status, for the older group, those with Medicare and private insurance
were most likely to have a usual source of care, and individuals with Medicare and public
insurance were least likely to have a usual source. Within each type of insurance, the
likelihood of having a usual source of health care was not different for survivors and
individuals without a cancer history (Appendix A, available online at www.ajpmonline.org).
Other aspects of perceived access also varied by type of insurance, but were not different for
older cancer survivors and other individuals within insurance categories (data not shown).
Realized Access to Care
In the group aged 18–64 years, cancer survivors were more likely than other individuals to
have had blood pressure or cholesterol evaluations, or influenza vaccinations in adjusted
analyses (Table 3). Among age- and gender-eligible individuals, higher proportions of
cancer survivors received cervical or colorectal cancer screening. In the group aged ≥65
years, the proportions with blood pressure and cholesterol evaluations were not different for
cancer survivors and other individuals, but older cancer survivors were more likely to have
received dental check-ups, influenza vaccinations, cervical or colorectal cancer screening.
Associations between cancer survivorship and realized access to care varied by type of
insurance in the population aged 18–65 years, in adjusted analyses. Among the privately
insured, cancer survivors were generally more likely to receive blood pressure or cholesterol
evaluations or dental check-ups than individuals without a cancer history, whereas among
the publicly insured or the uninsured, cancer survivors were generally less likely to receive
preventive services (Appendixes B and C, available online at www.ajpmonline.org). For
example, having a recent dental check-up was more likely in cancer survivors than in
individuals without a cancer history among those with private health insurance, (72.5% vs
69.3%) but less likely among those with public health insurance (36.5% vs 49.4%) or those
who were uninsured (30.9% vs 36.5%, p<0.001 for interaction). Receipt of cancer screening
among age-eligible adults was not different for cancer survivors and other individuals within
insurance categories (data not shown).
In the population aged ≥65 years, preventive service use was highest for individuals with
Medicare and supplemental private insurance, and lower for those with Medicare only or
Medicare and public insurance, regardless of cancer history. In contrast to the patterns in the
younger group, older cancer survivors consistently made equivalent or greater use of
preventive services than individuals without a cancer history with the same insurance type
(Appendixes D and E, available online at www.ajpmonline.org). Among cancer survivors in
both age groups, preventive service use and cancer screening, varied little by time since
diagnosis, in adjusted analyses (data not shown).
Discussion
Overall, cancer survivors of all ages were more likely to have access to care and equivalent
or greater preventive services use across multiple measures compared to other individuals.
Although these findings are encouraging, there is still room for improved care for cancer
survivors, particularly because they have increased risk of developing other cancers and may
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experience late or lasting effects of treatment.3,4,27,28 For example, the proportion of cancer
survivors aged 50–64 years and ≥65 years receiving colorectal cancer screening was 58.5%
and 62.5%, respectively, whereas the 2020 Healthy People29 target is 70.5%. Ongoing
monitoring is important for ensuring that all cancer survivors reach these important
preventive health goals.
Striking effects of health insurance on access to care and preventive services use for cancer
survivors and individuals without a cancer history were observed across multiple measures.
The uninsured and publicly insured had diminished access to care and were less likely to use
preventive services compared to the privately insured, as reported elsewhere.9 However, in
the group aged 18–64 years, privately insured cancer survivors were more likely to have
access to care and use preventive services than individuals without a cancer history, whereas
publicly insured or uninsured cancer survivors were generally less likely to have access to
care. As a result, disparities in access by type of insurance were greater for cancer survivors
than for individuals without a cancer history.
Although some of the disparities by type of insurance are relatively modest, their impact
may be large because approximately 40% of the 12 million cancer survivors are aged <65
years. Because this is one of the first studies to explore health insurance type and perceived
and realized access to care for cancer survivors in detail, some of these findings are
hypothesis-generating. For example, disparities by type of insurance coverage for younger
cancer survivors and differences by age suggest that further exploration of the role of health
insurance in accessing care, including ease of making timely appointments and having a
network of providers, and the impact of delaying or being unable to get necessary care, will
be important in efforts to improve survivorship care. These findings provide an important
baseline for understanding the effects of health insurance expansions on cancer survivorship
care.
Findings of equivalent or greater reported preventive services use for older survivors
compared to older individuals without a cancer history, regardless of health insurance, while
consistent with other studies conducted in samples of prevalent cancer survivors14,18,20
differs from most SEER-Medicare cohort studies, even when stratified by time since
diagnosis. Prior studies using Medicare claims conducted in cohorts of cancer survivors
aged ≥65 years with a single type of cancer and single time since diagnosis generally
reported less use of preventive services by cancer survivors.15,17 One of the few exceptions
reported higher use of preventive services in a population of long-term breast cancer
survivors.16 Importantly, when the sample without cancer was restricted to those who had
mammography in the same 2–year period as the breast cancer diagnosis (making past use of
mammography similar in the two groups), apparent differences in the use of most other
preventive services between survivors and controls were eliminated.16 Future work
exploring the inter-relationship between time since diagnosis, usual source of care, type of
insurance, and use of preventive services is needed, particularly for cancers with effective
screening tests.
Limitations
Despite the strengths of a large nationally representative sample of adults of all ages and all
types of insurance and the consistency of findings across multiple measures, this study has
several limitations. Cancer survivors were identified by survey responses, and information
about stage at diagnosis, treatment(s), recurrence, or other clinical characteristics was not
available. Details about onset of comorbid conditions in relation to cancer treatment or the
role of oncologists in usual care and care coordination that would have allowed a more
sophisticated analysis of access to care were also not available. Perhaps more importantly,
population-based surveys generally include only small numbers of newly diagnosed, rare
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cancers, or cancers associated with short survival, and mainly consist of long-term survivors
of common adult cancers; often participating many years after their diagnosis. Evaluation of
perceived and realized access to care in populations of survivors with rare cancers and short
survival is important for future research. Finally, information about access to care in the
MEPS was based on survey responses.
Conclusion
Although access to care and use of preventive services in cancer survivors is generally
equivalent or greater compared to other individuals, there are important disparities for
publicly insured or uninsured cancer survivors aged 18–64 years. Efforts to improve access
for these groups are needed, particularly in light of ongoing health insurance expansions in
the U.S. Ongoing efforts to improve adherence to preventive service recommendations for
the more than 12 million cancer survivors are important.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Usual source of health care by type of health insurance, ages 18–64 years
Note: p-value=0.02 for interaction between health insurance type and cancer survivor status
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